- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04374786
Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic
Effects of a Mobile App on Health and Well-being During COVID-19 Pandemic in House Staff at Banner University Medical Center Phoenix
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The COVID-19 global pandemic is significantly impacting healthcare providers and presumably affecting their stress level as they deal with this time of uncertainty. The COVID-19 public health crisis requires the full resources and attention of healthcare systems. This has led to several healthcare changes that affect physicians in training, including changes to rotations and schedules, risks of infection exposure to themselves or their families, and the unknown impacts this may have on their residency and fellowship experiences.
These changes are likely impacting their stress, health, and well-being. Physician burnout is major concern for the medical community and likely to be further impacted by the current pandemic. Evidence-based interventions for stress include cognitive behavior therapy, although this can be time consuming, requires the need for specialized providers, and is not feasible for everyone during this COVID-19 pandemic. Pharmacotherapy can be used, including antidepressants and anxiolytics, however they have inherent limitations such as side effects, tolerance, and interactions that limit their use. Consumer based mobile applications (apps) may help individuals with self-management strategies for stress. Mindfulness meditation is one type of self-management strategy and is the practice of moment-to-moment awareness in which the person purposefully focuses on the present without judgement.
"Calm" is a mobile app that offers a range of meditation lessons, sleep stories (bed-time stories for grown-ups), sleep music, and nature sounds with modules that vary in length, instruction, and content. Few studies on the use of "Calm" exist and include a randomized controlled trial evaluating its affect to decrease stress among college students and a descriptive study evaluating cancer patient's perceptions of the app. There is evidence to support the use of similar apps in resident physicians. A pilot study assessing the effects of a meditation app on resident wellness suggested both the feasibility and efficacy of such an intervention. During these unprecedented times of the COVID-19 pandemic, mobile apps such as Calm may be potentially beneficial to help with stress in house staff physicians, although this requires further investigation.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85006
- Banner University Medical Center Phoenix
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All resident and fellow physicians at Banner University Medical Center Phoenix, 1111 E. McDowell Rd, Phoenix, AZ 85006.
Exclusion Criteria:
- Non-resident and fellow physicians at Banner University Medical Center Phoenix, 1111 E. McDowell Rd, Phoenix, AZ 85006.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Group
Will receive a 30-day are trial of the mobile meditation app "Calm" on study day 0
|
Meditation is a self-management strategy that can be utilized by anyone to assist with the management of stress.
Meditation mobile applications, such as the "Calm" app, can be used to help manage stress, especially during this uncertain time.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Perceived Stress Scale
Time Frame: Completed study Day 0
|
Validated perceived stress scale survey, 10 questions in length rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often).
Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items.
Individual scores can range from 0 to 40 with higher scores indicating higher perceived stress.
|
Completed study Day 0
|
Perceived Stress Scale
Time Frame: Completed study Day 14
|
Validated perceived stress scale survey, 10 questions in length rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often).
Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items.
Individual scores can range from 0 to 40 with higher scores indicating higher perceived stress.
|
Completed study Day 14
|
Perceived Stress Scale
Time Frame: Completed study Day 30
|
Validated perceived stress scale survey, 10 questions in length rated on a 5-point Likert scale ranging from 0 (never) to 4 (very often).
Scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items.
Individual scores can range from 0 to 40 with higher scores indicating higher perceived stress.
|
Completed study Day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hospital Anxiety and Depression Scale
Time Frame: Completed study Day 0, 14, and study Day 30
|
Validated anxiety and depression scale survey, 14 questions in length rated on a 4-point Likert scale.
Possible scores range from 0 to 21 for anxiety and 0 to 21 for depression with higher scores indicating probable presence of the mood disorder.
|
Completed study Day 0, 14, and study Day 30
|
PROMIS Sleep Disturbance Short Form Survey
Time Frame: Completed study Day 0, 14, and study Day 30
|
Patient Reported Outcomes Measurement Information System (PROMIS) is a validated sleep disturbance short form survey, 8 questions in length rated on a 5-point Likert scale ranging from 1 (not at all) to 5 (very much).
Possible scores range from 0 to 21 for anxiety and 0 to 21 for depression with higher scores indicating greater severity of sleep disturbance.
|
Completed study Day 0, 14, and study Day 30
|
Impact of Event Scale-6
Time Frame: Completed study Day 0, 14, and study Day 30
|
The Impact of Event Scale-6 is a validated post traumatic event survey, 6 questions in length rated on a 5-point Likert scale ranging from 1 (not at all) to 5 (extremely).
The score ranges from a minimum of 6 to a maximum of 30 with higher scores indicating higher traumatic stress.
|
Completed study Day 0, 14, and study Day 30
|
Maslach Burnout Inventory
Time Frame: Completed study Day 0, 14, and study Day 30
|
The Maslach Burnout Inventory is a validated burnout survey, 22 questions in length with 3 sub scales including emotional exhaustion, depersonalization, and personal accomplishment.
Each question is rated on a 7 point Likert scale ranging from 0 (never) to 6 (every day).
The score for each sub scales range from minimum 0 to maximum 18. High scores of emotional exhaustion and depersonalization sub scales and a lower score of personal accomplishment indicates a higher level of burnout.
|
Completed study Day 0, 14, and study Day 30
|
Adherence
Time Frame: From Day 0 to Day 30
|
Usage data from mobile app, minutes per day used
|
From Day 0 to Day 30
|
Coronavirus Questionnaire
Time Frame: Completed study Day 0 and study Day 30
|
Investigator developed questionnaire about perceptions on coronavirus completed on Day 0 and Day 30, 10 questions in length and measured with 5-point Likert scale.
1= very low, 2=low, 3=moderate, 4=high, 5= very high.
|
Completed study Day 0 and study Day 30
|
Participant Satisfaction
Time Frame: Completed study Day 30
|
Investigator developed satisfaction questionnaire completed on Day 30, 13 questions in length.
|
Completed study Day 30
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Mike Foley, MD, Chair - BUMCP
Publications and helpful links
General Publications
- Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the Mindfulness Meditation Mobile App "Calm" to Reduce Stress Among College Students: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Jun 25;7(6):e14273. doi: 10.2196/14273.
- Huberty J, Vranceanu AM, Carney C, Breus M, Gordon M, Puzia ME. Characteristics and Usage Patterns Among 12,151 Paid Subscribers of the Calm Meditation App: Cross-Sectional Survey. JMIR Mhealth Uhealth. 2019 Nov 3;7(11):e15648. doi: 10.2196/15648.
- Huberty J, Puzia M, Eckert R, Larkey L. Cancer Patients' and Survivors' Perceptions of the Calm App: Cross-Sectional Descriptive Study. JMIR Cancer. 2020 Jan 25;6(1):e16926. doi: 10.2196/16926.
- Wen L, Sweeney TE, Welton L, Trockel M, Katznelson L. Encouraging Mindfulness in Medical House Staff via Smartphone App: A Pilot Study. Acad Psychiatry. 2017 Oct;41(5):646-650. doi: 10.1007/s40596-017-0768-3. Epub 2017 Aug 9.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Nervous System Diseases
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Sleep Wake Disorders
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- COVID-19
- Dyssomnias
- Parasomnias
Other Study ID Numbers
- 2003524869 [Sub-study]
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on PTSD
-
University of PittsburghCompletedPTSD | Non PTSDUnited States
-
Imperial College Healthcare NHS TrustImperial College LondonRecruiting
-
VA Office of Research and DevelopmentUniversity of California, San DiegoRecruiting
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Active, not recruiting
-
Oregon Health and Science UniversityEnrolling by invitation
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentPortland VA Medical CenterActive, not recruiting
-
VA Office of Research and DevelopmentSan Diego Veterans Healthcare SystemCompleted
-
Creighton UniversityCompleted
-
VA Eastern KansasTerminated
Clinical Trials on Calm Meditation App
-
The University of Texas Health Science Center at...Arizona State UniversityWithdrawn
-
Arizona State UniversityCompletedMyeloproliferative NeoplasmUnited States
-
Calm.com, Inc.The University of Texas Health Science Center at San Antonio; Arizona State...Completed
-
Arizona State UniversityThe University of Texas Health Science Center at San AntonioCompleted
-
University of ArizonaCompletedAnxiety | Sleep Disturbance | Perceived StressUnited States
-
Arizona State UniversityCompletedMeditation | Control GroupUnited States
-
Calm.com, Inc.TerminatedPregnancy RelatedUnited States
-
Johns Hopkins UniversityTerminatedSystemic Lupus Erythematosus | Vasculitis | Inflammatory Arthritis | Myositis | Sjogren's Syndrome | SclerodermaUnited States
-
Arizona State UniversityCompletedSleep Disturbance | Mental Health Wellness 1United States